Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

artemisinin‐based combination medicines,ACT

Effects and efficacy:
Used to treat vivax malaria, severe malignant malaria resistant to chloroquine and cerebral malaria.
Usage and dosage:
Oral administration: 1g first, then 0.5g after 6-8 hours, 0.5g on the 2nd and 3rd day, 3 days of treatment, total 2.5g. Total dose for children: 15mg/kg, take it within 3 days as above. Rectal administration: 0.6g for the first time, 0.6g after 6 hours, 0.4g on the 2nd and 3rd day. Deep intramuscular injection: 200mg for the first time, 100mg after 6-8 hours, 100mg on the 2nd and 3rd day, total dose 500mg (100mg on the 4th day for some severe cases). Or use it for 3 consecutive days, 300mg intramuscularly every day, total 900mg. 15mg/kg for children, take it within 3 days as above.
Adverse reactions:
Some patients may experience transient increase in aminotransferase and mild rash. A few cases have mild nausea, vomiting, diarrhea and other adverse reactions, which can quickly return to normal without treatment. ECG abnormalities, including Q-T interval prolongation. Animal experiments have confirmed that large doses can cause severe neurotoxicity. When the injection site is shallow, it is easy to cause local pain and lumps.
Drug contraindications:
Allergic to this product is prohibited. Use with caution during lactation. Use with caution during pregnancy. Use with caution in case of liver function damage.


Featured products

Laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor.